In the era of targeted therapies, test and platform developers face numerous challenges. Identifying emerging trends, portfolio opportunities and competitive intelligence that precisely match your strategic goals is slow and costly with ad-hoc research. The ideal opportunities are often missed, and the wrong products may be pursued. How can you improve access to the information you need at the right time to optimize your product development roadmap?
Transitioning to a mature product development strategy requires advanced intelligence and machine learning to enable opportunity exploration, product planning and decision making on a real time, continuous basis. This allows strategic product development planning efforts to be optimized and prioritized continuously, ensuring efficient investment in timely, well-vetted, evidence-based product opportunities.